Caliper's Revenues Down on Divestitures; Net Loss Drops 33 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its first-quarter revenues declined 3 percent, as divestitures and currency effects hit its top line, but increased 11 percent on an organic basis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.